Skip to main content
. 2021 Sep 16;125(11):1593–1597. doi: 10.1038/s41416-021-01541-4

Table 2.

Number of participants with features of possible cancer in selected risk bands (and comparison to PPV ≥ 3%), in 150,921 English patients aged ≥40 years.

PPV ≥ 3% PPV ≥ 2% PPV ≥ 1%
Number qualifying Additional number qualifying for PC testing Estimated number positive tests Adjusted number qualifying for referral after PC testing Adjusted number/100,000 population after PC testing [95% CI] Number qualifying Additional number qualifying for PC testing Estimated number positive tests Adjusted number qualifying for referral after PC testing % change from PPV ≥ 3% Adjusted number/100,000 population after PC testing [95% CI] Number qualifying % change from PPV ≥ 3% Number/100,000 population [95% CI]
Colorectal 5125 1776 282 5407 3583 [3489, 3678] 5440 1461 232 5672 5 3758 [3663, 3855] 6901 28 4573 [4468, 4679]
Prostate 894 894 592 [554, 632] 1046 1046 17 693 [652, 736] 1126 26 746 [703, 791]
Lung 803 2503 30 833 552 [515, 591] 963 2343 28 991 19 657 [617, 699] 3306 297 2191 [2117, 2266]
Breast 293 293 194 [173, 218] 311 311 6 206 [183, 231] 474 62 314 [286, 344]
Kidney 263 263 174 [154, 197] 263 263 0 174 [154, 197] 961 265 637 [597, 678]
Bladder 246 246 163 [143, 184] 246 246 0 163 [143, 185] 841 242 557 [520, 596]
Upper GI 211 211 140 [122, 160] 249 249 18 165 [145, 187] 5044 2291 3342 [3252, 3434]
Ovary 128 31 2 130 86 [72, 102] 149 10 1 150 15 99 [84, 117] 159 22 105 [90, 123]
Endometrium 109 109 72 [59, 87] 124 124 14 82 [68, 98] 244 124 162 [142, 183]
Larynx 111 111 74 [61, 89] 142 142 28 94 [79, 111] 142 28 94 [79, 111]
Pancreas 78 78 52 [41, 65] 97 97 24 64 [52, 78] 319 309 211 [189, 236]
Totals 8261a 8576 5682 [5566, 5800] 9030b 9291 8 6156 [6035, 6279] 19517c 136 12932 [12763, 13102]

The risk bands are cumulative. Thus a participant in the ≥3% risk band also appears in the ≥2% risk band and the ≥1% risk band.

Upper GI upper gastrointestinal (oesophagus or stomach), PC primary care.

aTotal of 8261 in 6898 unique participants.

bTotal of 9030 in 7453 unique participants.

cTotal of 19,517 in 10,649 unique participants.